20.83
price up icon6.04%   1.22
 
loading
Schlusskurs vom Vortag:
$19.61
Offen:
$19.72
24-Stunden-Volumen:
83,663
Relative Volume:
0.23
Marktkapitalisierung:
$386.06M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-26.04
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
-4.08%
1M Leistung:
+1.44%
6M Leistung:
+128.02%
1J Leistung:
+298.37%
1-Tages-Spanne:
Value
$19.50
$21.06
1-Wochen-Bereich:
Value
$19.50
$22.25
52-Wochen-Spanne:
Value
$3.78
$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name
Firmenname
Optimizerx Corp
Name
Telefon
248-651-6558
Name
Adresse
260 CHARLES STREET, WALTHAM, MI
Name
Mitarbeiter
129
Name
Twitter
@OpRxTweets
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
OPRX's Discussions on Twitter

Vergleichen Sie OPRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
OPRX
Optimizerx Corp
20.80 364.06M 62.81M -13.75M 153.00K -0.80
Health Information Services icon
VEEV
Veeva Systems Inc
289.52 46.72B 2.97B 809.93M 1.33B 4.8743
Health Information Services icon
TEM
Tempus Ai Inc
89.45 14.99B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
66.71 12.33B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
94.78 8.01B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
37.27 7.09B 906.14M -52.62M 89.62M -0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-08 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-12-20 Eingeleitet Stephens Equal-Weight
2024-07-25 Fortgesetzt B. Riley Securities Buy
2024-04-04 Eingeleitet JMP Securities Mkt Outperform
2024-01-03 Eingeleitet Barclays Equal Weight
2023-02-02 Fortgesetzt B. Riley Securities Buy
2022-11-01 Eingeleitet Stifel Buy
2022-07-15 Eingeleitet SVB Leerink Outperform
2021-10-18 Fortgesetzt B. Riley Securities Buy
2021-04-13 Eingeleitet RBC Capital Mkts Outperform
2019-01-03 Eingeleitet William Blair Outperform
Alle ansehen

Optimizerx Corp Aktie (OPRX) Neueste Nachrichten

pulisher
08:31 AM

OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat

08:31 AM
pulisher
06:58 AM

OptimizeRx Corporation stock chart pattern explained2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com

06:58 AM
pulisher
06:25 AM

OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

06:25 AM
pulisher
02:55 AM

Why OptimizeRx Corporation stock attracts global investorsShare Buyback & Capital Protection Trading Alerts - newser.com

02:55 AM
pulisher
Oct 30, 2025

OptimizeRx (NASDAQ: OPRX) sets Q2 results call Aug 7 via webcast and dial-in access - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

OptimizeRx Corp. Hits New 52-Week High of $21.99, Up 90% Yearly - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Can OptimizeRx Corporation stock attract ESG capital inflowsJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

OptimizeRx Corporation stock outlook for YEARWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Why OptimizeRx Corporation stock appeals to analystsWeekly Gains Report & Weekly Market Pulse Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Profit Report & Long-Term Safe Return Strategies - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

What insider trading reveals about OptimizeRx Corporation stockPortfolio Value Report & Capital Efficient Trade Techniques - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Aug Outlook: Why OptimizeRx Corporation stock appeals to analystsJobs Report & Free Safe Capital Growth Stock Tips - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Why analysts upgrade OptimizeRx Corporation stockEarnings Overview Summary & Safe Capital Preservation Plans - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is now a turning point for OptimizeRx CorporationJuly 2025 Trends & High Conviction Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will OptimizeRx Corporation stock recover faster than marketJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is OptimizeRx Corporation stock recession proofJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is OptimizeRx Corporation stock in correction or buying zoneNew Guidance & Safe Entry Trade Reports - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat

Oct 26, 2025
pulisher
Oct 24, 2025

OptimizeRx Stock Delivers Over 90% Gain In Six MonthsA Prescription For Portfolio Growth? - RTTNews

Oct 24, 2025
pulisher
Oct 21, 2025

Pattern recognition hints at OptimizeRx Corporation upsideStock Surge & Reliable Momentum Entry Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Does OptimizeRx Corporation qualify in momentum factor screening2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Real time social sentiment graph for OptimizeRx CorporationJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET - The Globe and Mail

Oct 20, 2025
pulisher
Oct 20, 2025

OptimizeRx Corp. Schedules Conference Call to Discuss Q3 2025 Financial Results - Quiver Quantitative

Oct 20, 2025
pulisher
Oct 20, 2025

Nov 6, 4:30 p.m. ET: OptimizeRx to Discuss Q3 2025 Results on Conference Call; replay 12 months - Stock Titan

Oct 20, 2025

Finanzdaten der Optimizerx Corp-Aktie (OPRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Optimizerx Corp-Aktie (OPRX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Option Exercise
0.00
6,649
0
190,536
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Sale
18.75
1,620
30,375
188,916
Stelmakh Edward
Chief Finance & Strat Officer
Oct 03 '25
Option Exercise
0.00
16,623
0
127,387
Besch Doug
Chief Product & Tech Officer
Oct 03 '25
Option Exercise
0.00
3,325
0
70,555
Spangler Patrick D
Director
Aug 28 '25
Sale
17.49
11,120
194,489
44,215
$11.51
price up icon 1.41%
$28.13
price down icon 0.02%
$24.60
price up icon 0.33%
$36.98
price up icon 0.50%
$32.77
price down icon 0.05%
health_information_services WAY
$37.21
price up icon 0.45%
Kapitalisierung:     |  Volumen (24h):